Pharmaceuticals

The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

23 Dec, 2024, 14:47 GMT Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the...

23 Dec, 2024, 05:39 GMT Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong ...

20 Dec, 2024, 13:30 GMT Medicilon Appoints Dr. Lilly Xu as Chief Technology Officer

Medicilon, a leading preclinical contract research organization (CRO), has named Dr. Lilly Xu as its new Chief Technology Officer (CTO). With over 30 ...

19 Dec, 2024, 21:40 GMT Innocan Pharma Announces Private Placement of Units

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a...

19 Dec, 2024, 15:30 GMT Cancer Vaccines Market to Hit USD 20.47 Billion by 2032 with 8.6% CAGR | MarketsandMarkets™.

The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, reaching US$10.61 billion in...

19 Dec, 2024, 09:07 GMT Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has completed the installation of two new...

19 Dec, 2024, 08:30 GMT TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001, a groundbreaking thrombolytic in acute ischemic stroke (AIS) and TTP

TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today...

19 Dec, 2024, 08:00 GMT Ottimo Pharma Raises over $140 Million in Series A Financing

Ottimo Pharma ("Ottimo"), a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, today...

19 Dec, 2024, 06:52 GMT BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers...

18 Dec, 2024, 15:01 GMT Therapeutic Drug Monitoring Market to Hit USD 3.44 Billion by 2029 with 8.4% CAGR | MarketsandMarkets™

The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD 3.44...

18 Dec, 2024, 13:30 GMT Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)

Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has ...

18 Dec, 2024, 08:02 GMT Implantica announces two new RefluxStop™ University Hospitals in Spain, leading to 10 active centers and many more to join soon

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™...

18 Dec, 2024, 06:00 GMT Neurizon Files IND Application to Support HEALEY ALS Platform Trial

(ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to ...

17 Dec, 2024, 22:18 GMT Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of...

17 Dec, 2024, 21:15 GMT Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will webcast its corporate presentation at the 43rd Annual J.P. Morgan...

17 Dec, 2024, 19:20 GMT Global Market for Drug-Device Combinations to Reach $200 Billion by End of 2029

According to the latest study from BCC Research, the demand for Global Markets for Drug-Device Combinations is expected to grow from $129.4 billion...

17 Dec, 2024, 16:00 GMT Pharmaceutical Filtration Market to Hit USD 20.97 Billion by 2029 with 9.5% CAGR | MarketsandMarkets™

The global Pharmaceutical Filtration market is expected to grow to USD 20.97 Billion by 2029, up from USD 13.31 Billion in 2024, at a CAGR of 9.5%...

17 Dec, 2024, 14:59 GMT Zentiva hosted the "European Health Check":

A live survey conducted during the "European Health Check" revealed that 77% of participants do not believe the current systemic framework applied to ...

17 Dec, 2024, 12:00 GMT BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that in anticipation of...

17 Dec, 2024, 10:31 GMT In-Depth Market Analysis of Rare Autoimmune Disorders: Myasthenia Gravis, Systemic Sclerosis, Axial Spondyloarthritis, and Idiopathic Inflammatory Myositis | DelveInsight

The rare autoimmune disorders market is evolving rapidly, driven by advancements in biotechnology and an increasing understanding of immune system...

17 Dec, 2024, 10:23 GMT Dubai's thriving co-working sector drives D/Quarters to double space at Dubai Science Park

D/Quarters, the provider of state-of-the-art co-working spaces by TECOM Group PJSC, has doubled the size of its centrally located offices at Dubai...

17 Dec, 2024, 07:31 GMT Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), continues to develop its innovative powder-based drug delivery technology AmorphOX to improve the...

16 Dec, 2024, 22:31 GMT CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period (2020-2034) | DelveInsight

CTLA-4 inhibitors are a well-established market in cancer care, and they are expected to grow significantly in the coming years. This is due to the...

16 Dec, 2024, 21:05 GMT Jazz Pharmaceuticals Announces CEO Succession Plan

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Bruce Cozadd, Co-Founder, Chairperson and Chief Executive Officer (CEO), has informed...

16 Dec, 2024, 15:30 GMT Vaccine Adjuvants Market to Hit USD 0.96 Billion by 2029 with 6.5% CAGR | MarketsandMarkets™

The global vaccine adjuvants market is anticipated to reach USD 0.96 billion by 2029 from USD 0.70 billion in 2024, with a significant CAGR of 6.5%....

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE